Stay updated on TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. There is no impact on the study page's content or how users interact with it.
    Difference
    0.1%
    Check dated 2026-01-14T01:22:50.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new Locations section listing North Carolina and Tennessee for trial sites. Removed the separate North Carolina Locations and Tennessee Locations sections.
    Difference
    0.3%
    Check dated 2025-12-23T12:30:09.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:17:27.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The notice about government funding and NIH operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:35:57.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study page content remains substantively unchanged between the screenshots; only cosmetic formatting differences are present and no edits to eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:19:31.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    4%
    Check dated 2025-10-06T04:26:55.000Z thumbnail image

Stay in the know with updates to TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.